Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort

INTRODUCTION: Ixekizumab has demonstrated efficacy in pivotal trials in patients with psoriatic arthritis (PsA), both those naïve to prior biologic therapy and those with prior inadequate response or intolerance to biologics; however, minimal information is currently available on the effectiveness o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tillett, William, Birt, Julie, Cavanaugh, Cristi, Jung, Yoojin, Vadhariya, Aisha, Ross, Sarah, Paulus, Jessica, Lubrano, Ennio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322216/
https://www.ncbi.nlm.nih.gov/pubmed/37415769
http://dx.doi.org/10.3389/fmed.2023.1184028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322216/
https://www.ncbi.nlm.nih.gov/pubmed/37415769
http://dx.doi.org/10.3389/fmed.2023.1184028

Ejemplares similares